LPL Financial
NRXP icon

LPL Financial’s NRX Pharmaceuticals NRXP Stock Holding History

LPL Financial’s Portfolio NRXP Stock Details NRXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,457
Closed -$6.88K – 5091
2024
Q1 		$6.88K Hold
1,457
– – ﹤0.01% 4896
2023
Q4 		$6.7K Buy
1,457
+221
+18% +$730 ﹤0.01% 4769
2023
Q3 		$3.21K Buy
+1,236
New +$4.11K ﹤0.01% 4677

Other funds holding NRXP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OWMIAS
One Wealth Management Investment & Advisory Services Miami Beach, Florida $95.3M AUM 25.31% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

LPL Financial's NRXP Position: Q2 2024 in Review

LPL Financial sold out of NRX Pharmaceuticals (NRXP) in Q2 2024, closing a stake of 1,457 shares — an estimated $6.88K sold.

LPL Financial first reported a position in NRXP in Q3 2023 and held it in 3 quarters. The position peaked at $6.88K in Q1 2024. 19 funds tracked by Wall St. Rank hold NRXP as of Q2 2024.

  • LPL Financial reported no remaining NRX Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • LPL Financial sold 1,457 NRX Pharmaceuticals shares in Q2 2024, an estimated $6.88K.
  • LPL Financial first reported a position in NRX Pharmaceuticals in Q3 2023 and held it in 3 quarters.
  • LPL Financial's NRX Pharmaceuticals position peaked at $6.88K in Q1 2024.
  • 19 funds tracked by Wall St. Rank held NRX Pharmaceuticals as of Q2 2024.

Based on LPL Financial's 13F filing for Q2 2024, filed 7 Aug 2024.